Stocks · US
NVS
XNYS
Novartis AG
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E39.64x
P/B3.70x
P/S5.38x
EPS$3.55
ROE9.33%
ROA5.14%
Dividend yield2.42%
EV/EBITDA22.03x
Debt/Equity0.22
Free cash flow$9.7B
Returns and 52-week range
1W-3.38%
1M-12.00%
3M-9.27%
6M-6.90%
1Y+6.34%
YTD+1.62%
52W high$170.46
52W low$121.57
From 52W high-17.41%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| 유나이티드헬스 그룹 | $339.8B | 24.06 | 3.45 | -5.24% |
| 써모 피셔 사이언티픽 | $250.2B | 35.92 | 4.75 | +6.97% |
| 머크 | $344.3B | 108.50 | 8.21 | -5.58% |
| 아스트라제네카 | $242.8B | 109.30 | 17.94 | -2.51% |
| 애브비 | $469.6B | 74.66 | — | +3.99% |
| 암젠 | $217.9B | 24.92 | 18.64 | -7.92% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.